Search
for
Sort by
Research 811–840 of 1000+
- Appearance and Internal Aging
- Unravelling the link between insulin resistance and androgen excess
- Nanocarriers for Improved Delivery of Angiotensin-(1-7)
- Definition criteria and diagnostic assessments
- Regenerative Medicine of Epidermal Structures
- Australasian Society for Dermatology Research Meeting, May 2006
- Lab Quality Management and Methodology
- Diffuser Haarausfall und klinische Endokrinologie: Neue Erkenntnisse
- Viewpoint 3
- Early onset androgenic alopecia as the male phenotypic equivalent of polycystic ovarian syndrome is associated in high oxidative stress
- Early-onset Male Androgenetic Alopecia and Metabolic Syndrome: Are They Associated?
- Association between androgenetic alopecia and cardiovascular risk factors according to BASP classification in Korean androgenetic alopecia
- Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Comorbidities in alopecia areata: A systematic review and meta-analysis
- Delivery and targeting of nanoparticles into hair follicles
- Acquired scalp alopecia. Part I: A review
- Mood disorders and quality of life in polycystic ovary syndrome
- Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
- Androgen antagonists in androgen target tissues
- Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review
- Testosterone Treatment in Women – An Overview
- Androgens and the Menopause
- Anabolic and Metabolic Effects of Testosterone and Other Androgens: Direct Effects and Role of Testosterone Metabolic Products
- Telogeneffluvium . Telogen effluvium
- Serum interleukin-37 and its gene polymorphism (rs3811047) in Egyptian patients with alopecia areata
- Studying Cytotoxic T-lymphocyte- Associated Antigen-4 (CTLA-4) gene Polymorphism in a Sample of Iraqi Women with Polycystic Ovarian Syndrome
- YKL-40 a sensitive biomarker for early androgenetic alopecia and early hidden metabolic syndrome
- Hair Loss: A Harbinger of the Morbidities to Come!
- From Anti-Aging Medicine to Precision Healthspan Pharmacology: Evidence Domains, Monitoring Requirements, and Practical Boundaries